Cinclus: Positive read-x, US market showing growing interest in PCABs
Phathom Pharma reported its Q2 report yesterday, which highlighted a positive launch of its 1st generation PCAB Voquezna (vonoprazan), where filled prescriptions amounted 35,000 (+265% QoQ) for the quarter, with 77% of total US commercial lives covered. We are encouraged by such a positive launch t
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.